OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1336$51.2060

New China Life Insurance Co Ltd

Life & Health InsuranceVerified

New China Life Insurance Co Ltd exhibits a low price-to-book ratio of 0.47 and a price-to-earnings ratio of 1.46, indicating a potential undervaluation relative to its book value and earnings. The company's liquidity position is characterized as medium, with a free cash flow of 24.29 billion CNY and a negative net cash position after subtracting total debt. The debt-to-equity ratio of 0.19 suggests a relatively conservative capital structure. The company's profitability is highlighted by a return on equity of 32.53%, significantly outperforming the typical industry benchmark for life and health insurers. However, its return on assets of 1.91% is below the median for its industry, indicating inefficiencies in asset utilization. The operating margin, derived from an operating income of 37.2 billion CNY on total assets of 1.9 trillion CNY, suggests a moderate level of operational efficiency. New China Life Insurance Co Ltd's revenue is concentrated in the domestic market, with no disclosed international operations. The company's three business segments—Traditional Insurance, Participating Insurance, and Other Business—each contribute to its revenue, though the exact proportions are not specified in the input data. The Traditional Insurance segment includes traditional life, health, and accident insurance, while the Participating Insurance segment features insurance with direct participation features. The company's growth trajectory is supported by a strong operating cash flow of 110.92 billion CNY and a net income of 36.28 billion CNY. Analysts have provided a mean price target of 47.68 CNY, with a median of 48.50 CNY, suggesting a potential upside from the current market price of 51.2 CNY. The company's revenue history and outlook indicate a stable but not aggressive growth path, with no specific numeric deltas provided for the current or next fiscal year. The risk assessment for New China Life Insurance Co Ltd identifies liquidity as a medium concern, with a low dilution risk. The company's capital structure is relatively stable, with a low debt-to-equity ratio and a manageable level of long-term debt. The risk of dilution is considered low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further supported by a conservative capital structure and a strong operating cash flow. Recent events and filings for New China Life Insurance Co Ltd include analyst estimates and price targets, with a mean recommendation of 2.93 (1=strong buy, 5=strong sell) and a range of price targets from 37.00 CNY to 58.00 CNY. The company's recent financial performance and market position suggest a stable outlook, with no significant negative events reported in the input data.

30-day price · 1336+0.94 (+2.0%)
Low$46.10High$53.90Close$48.10As of22 May, 00:00 UTC
Profile
CompanyNew China Life Insurance Co Ltd
Ticker1336.HK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. New China Life Insurance Co Ltd is a China-based company engaged in life insurance and asset management, operating through three segments: Traditional Insurance, Participating Insurance, and Other Business.

Classification. New China Life Insurance Co Ltd is classified under the Financials sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

New China Life Insurance Co Ltd exhibits a low price-to-book ratio of 0.47 and a price-to-earnings ratio of 1.46, indicating a potential undervaluation relative to its book value and earnings. The company's liquidity position is characterized as medium, with a free cash flow of 24.29 billion CNY and a negative net cash position after subtracting total debt. The debt-to-equity ratio of 0.19 suggests a relatively conservative capital structure. The company's profitability is highlighted by a return on equity of 32.53%, significantly outperforming the typical industry benchmark for life and health insurers. However, its return on assets of 1.91% is below the median for its industry, indicating inefficiencies in asset utilization. The operating margin, derived from an operating income of 37.2 billion CNY on total assets of 1.9 trillion CNY, suggests a moderate level of operational efficiency. New China Life Insurance Co Ltd's revenue is concentrated in the domestic market, with no disclosed international operations. The company's three business segments—Traditional Insurance, Participating Insurance, and Other Business—each contribute to its revenue, though the exact proportions are not specified in the input data. The Traditional Insurance segment includes traditional life, health, and accident insurance, while the Participating Insurance segment features insurance with direct participation features. The company's growth trajectory is supported by a strong operating cash flow of 110.92 billion CNY and a net income of 36.28 billion CNY. Analysts have provided a mean price target of 47.68 CNY, with a median of 48.50 CNY, suggesting a potential upside from the current market price of 51.2 CNY. The company's revenue history and outlook indicate a stable but not aggressive growth path, with no specific numeric deltas provided for the current or next fiscal year. The risk assessment for New China Life Insurance Co Ltd identifies liquidity as a medium concern, with a low dilution risk. The company's capital structure is relatively stable, with a low debt-to-equity ratio and a manageable level of long-term debt. The risk of dilution is considered low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further supported by a conservative capital structure and a strong operating cash flow. Recent events and filings for New China Life Insurance Co Ltd include analyst estimates and price targets, with a mean recommendation of 2.93 (1=strong buy, 5=strong sell) and a range of price targets from 37.00 CNY to 58.00 CNY. The company's recent financial performance and market position suggest a stable outlook, with no significant negative events reported in the input data.
Key takeaways
  • New China Life Insurance Co Ltd is undervalued based on its low price-to-book and price-to-earnings ratios.
  • The company's return on equity is significantly higher than the industry median, indicating strong profitability.
  • The company's liquidity position is medium, supported by a strong operating cash flow.
  • The company's risk profile is characterized by low dilution risk and a conservative capital structure.
  • Analysts have provided a range of price targets, suggesting a potential upside from the current market price.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue
Gross profit
Operating income$37.20B
Net income$36.28B
R&D
SG&A
D&A
SBC
Operating cash flow$110.92B
CapEx-$1.48B
Free cash flow$24.29B
Total assets$1.90T
Total liabilities$1.79T
Total equity$111.54B
Cash & equivalents
Long-term debt$20.80B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$37.20B$36.28B$24.29B
FY-1$28.22B$26.23B$21.96B
FY-2$5.54B$8.71B$4.37B
FY-3$22.09B$21.50B$16.41B
FY-4$15.63B$14.95B$8.41B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.90T$111.54B
FY-1$1.69T$96.24B
FY-2$1.40T$105.07B
FY-3$1.21T$97.97B
FY-4$1.13T$108.50B
PeriodOCFCapExFCFSBC
FY0$110.92B-$1.48B$24.29B
FY-1$96.29B-$1.10B$21.96B
FY-2$91.55B-$2.09B$4.37B
FY-3$88.52B-$1.79B$16.41B
FY-4$73.85B-$3.26B$8.41B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$6.67B$6.50B
FQ-1$240.0M$3.43B
FQ-2$20.70B$18.06B
FQ-3$10.25B$8.92B
FQ-4$6.01B$5.88B
FQ-5$4.90B$5.55B
FQ-6$11.36B$9.60B
FQ-7$6.80B$6.14B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$1.85T$123.56B$36.16B
FQ-1$1.90T$111.54B
FQ-2$1.83T$100.51B$28.76B
FQ-3$1.78T$83.41B
FQ-4$1.75T$79.85B$41.66B
FQ-5$1.69T$96.24B
FQ-6$1.67T$91.04B$23.47B
FQ-7$1.49T$90.03B
PeriodOCFCapExFCFSBC
FQ0$36.31B-$205.0M
FQ-1$110.92B-$1.48B
FQ-2$90.17B-$790.0M
FQ-3$58.72B-$413.0M
FQ-4$33.59B-$144.0M
FQ-5$96.29B-$1.10B
FQ-6$88.79B-$721.0M
FQ-7$61.11B-$732.0M
Valuation
Market price$51.20
Market cap$52.95B
Enterprise value$73.75B
P/E1.5
Reported non-GAAP P/E
EV/Revenue
EV/Op income2.0
EV/OCF0.7
P/B0.5
P/Tangible book0.5
Tangible book$111.54B
Net cash-$20.80B
Current ratio
Debt/Equity0.2
ROA1.9%
ROE32.5%
Cash conversion3.1%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
Metric1336Activity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity19.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Observations
IR observations
Mean price target47.68 CNY
Median price target48.50 CNY
High price target58.00 CNY
Low price target37.00 CNY
Mean recommendation2.93 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count3.00
Hold count5.00
Sell count4.00
Strong-sell count1.00
Mean EPS estimate8.46 CNY
Last actual EPS11.63 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 08:25 UTC#5d8ddedc
Market quoteclose CNY 51.20 · shares 1.03B diluted
no public URL
2026-05-01 08:25 UTC#582feba7
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 08:26 UTCJob: 152240c4